Ocrelizumab use in multiple sclerosis: a real-world experience in a changing therapeutic scenario

ConclusionOCR has been confirmed to be a highly efficacious option for patients with PP and RR MS, even proving to be a valid exit strategy for natalizumab.
Source: Neurological Sciences - Category: Neurology Source Type: research